ライフサイエンスコーパス: clinic visit

1 ermined on entry into the study (initial PAH clinic visit).

2 d up longitudinally over 1 year (1,166 total clinic visits).

3 itive test results out of 157 tests and 3934 clinic visits).

4 FP, or both since the last completed annual clinic visit.

5 uncertain and Doppler measurements require a clinic visit.

6 be performed on the same day as the initial clinic visit.

7 during a prospectively scheduled outpatient clinic visit.

8 57%) had active arthritis at the time of the clinic visit.

9 atients initiated ADT at the first or second clinic visit.

10 septic shock, and the other as an uneventful clinic visit.

11 icipants followed until at least the 6-month clinic visit.

12 al benefit assessments were recorded at each clinic visit.

13 37) measurements collected during the second clinic visit.

14 seline to 2 to 7 days and 3 months after the clinic visit.

15 panish to patients with LTBI at the first TB clinic visit.

16 and by patient survey at 3 months after the clinic visit.

17 ipants who returned for at least 1 quarterly clinic visit.

18 number, and they were contacted before their clinic visit.

19 ires and were audiotaped during a subsequent clinic visit.

20 uterised database at the time of their first clinic visit.

21 festyle questionnaire and were examined at a clinic visit.

22 ch was mailed to all patients 1 week after a clinic visit.

23 ry were eligible at the time of their 5-year clinic visit.

24 chomatis during a pelvic examination at each clinic visit.

25 and participated in a 1988 to 1991 follow-up clinic visit.

26 18) initiated ART within 3 mo of their first clinic visit.

27 ations on the day of their first HIV-related clinic visit.

28 ice (19.5%) of being notified in person at a clinic visit.

29 sions; (4) 18 HSV-2 seronegative women at 45 clinic visits.

30 um collection and reporting requires several clinic visits.

31 , parity, and number and timing of antenatal clinic visits.

32 use, and unscheduled emergency department or clinic visits.

33 cians and patients with cancer in ambulatory clinic visits.

34 ng at the baseline and 15-month and 30-month clinic visits.

35 n inverse trend with the number of antenatal clinic visits.

36 deaths, 8781 hospitalizations, and 1,443,883 clinic visits.

37 s were obtained from patients during routine clinic visits.

38 hnique to surveillance data collected during clinic visits.

39 t BP traits collected at the first two SAFHS clinic visits.

40 red for PTDM by 12-hour FPG levels drawn for clinic visits.

41 AIMS was delivered by nurses during routine clinic visits.

42 ted from sputum cultures at 22 of 23 monthly clinic visits.

43 metric assessments at baseline and follow-up clinic visits.

44 individual cessation counseling during nine clinic visits.

45 s, placebo and psychotherapy, or placebo and clinic visits.

46 atient days, and more than 500000 outpatient clinic visits.

47 ume in 1 s (FEV1) were measured at follow-up clinic visits.

48 nd remained slightly elevated during routine clinic visits.

49 m two patients during ACS and during routine clinic visits.

50 5.5 in the second year, with a mean of 14.8 clinic visits.

51 MQAS or SPAQ once every 2 months at routine clinic visits.

52 and blood hormone levels obtained at weekly clinic visits.

53 hile decreasing the burden of treatments and clinic visits.

54 self-ratings completed every 2 weeks during clinic visits.

55 ex (BMI) were measured at up to seven annual clinic visits.

56 rt and hope was completed at the first three clinic visits.

57 (CTCAE) via tablet computers at 5 successive clinic visits.

58 change the content of communications during clinic visits.

59 re are calculated based on attended HIV care clinic visits.

60 and complications were determined at routine clinic visits.

61 urated and NYHA functional class I at latest clinic visit (0.3 to 88.4 months postoperatively).

62 ied by the pharmacist at the patient's first clinic visit (1.1 errors per patient).

63 During their annual clinic visit, 101 adult survivors of childhood cancer (m

64 Among clinic-visits, 1212 subjects (53.7%) were using antihype

65 s occurred in the respiratory tract, between clinic visits 13 and 14.

66 s the most common GI symptom that prompted a clinic visit (15.9 million visits).

67 ease in per-1000-member rates of after-hours clinic visits (18.7 per 1000 members per year; 95% CI, 1

68 mation on BMI and physical activity during a clinic visit 2 to 3 years after diagnosis.

69 Information from >300 000 clinic visits (2.8 million data points) collected over 5

70 Information from more than 300 000 clinic visits (2.8 million data points) were collated.

71 2.8-5.2) and more selected LARCs during the clinic visit (224 [28%] vs 117 [17%], 1.9, 1.3-2.8).

72 rsisted until at least the time of the first clinic visit (3.4 errors per patient, p < 0.0001).

73 Over the course of 1,188 clinic visits, 370 childhood cancer survivors (53% male;

74 months, the 81 patients made a total of 1975 clinic visits, 374 of which were made during exacerbatio

75 [CI], 4%-36%); nortriptyline and medication clinic visits, 43 % (95% CI, 25%-61%); IPT and placebo,

76 s (17.3% vs 44.4%; P < .001), median monthly clinic visits (5 vs 20; P < .001), and median number of

77 Over 81 months, 104 patients made 3,009 clinic visits, 560 during exacerbations.

78 %), 5724 hospitalizations (65%), and 852,589 clinic visits (59%) and would save 58 disability-adjuste

79 n within the first 10 d after therapy, and a clinic visit 6-8 mo after therapy.

80 95% CI, 45%-83%); and placebo and medication clinic visits, 90% (95% CI, 79%-100%).

81 All underwent a clinic visit after a median follow-up of 13 years.

82 iagnosis, adjusting for age, race, number of clinic visits, alcohol use disorders, prostate cancer, a

83 Of these, 2680 attended a clinic visit an average of 14.9 years after baseline; me

84 rom the ED, 98 (54.4%) attended a first nPEP clinic visit and 43 (23.9%) had documented completion of

85 tween measured weight at the first antenatal clinic visit and at 18 mo postpartum.The median retained

86 nt associations between use of nitrates at 1 clinic visit and new JSN (odds ratio [OR] 1.94, 95% conf

87 me was selection of an IUD or implant at the clinic visit and secondary outcome was pregnancy within

88 visits associated with HMPV infection was 55 clinic visits and 13 emergency department visits per 100

89 children during the 2002-2003 season and 95 clinic visits and 27 emergency department visits per 100

90 ient visits associated with influenza was 50 clinic visits and 6 emergency department visits per 1000

91 ehensive care resulted in a mean of 3.1 more clinic visits and 6.7 more telephone conversations with

92 lacks had a lower rate of medical outpatient clinic visits and a higher rate of urgent care/emergency

93 ces, measured by attendance of all scheduled clinic visits and acceptance of proposed services up to

94 n the condition that they attended scheduled clinic visits and accepted offered PMTCT services (US$5,

95 116 in the control group (54%) attended all clinic visits and accepted proposed services (RR 1.26; 9

96 Attendance at scheduled clinic visits and adherence with study medication were s

97 valuations should take into account multiple clinic visits and assess whether criteria are appropriat

98 were assessed in a systematic manner at all clinic visits and by phone between visits.

99 mean age: 60 y; range: 36-83 y) who attended clinic visits and completed food-frequency questionnaire

100 participate in an ongoing program of serial clinic visits and functional and clinical evaluations.

101 troenteritis (AGE) remains a common cause of clinic visits and hospitalizations in the United States,

102 Activity Index (SLEDAI) were scored for all clinic visits and hospitalizations.

103 e assessed by questionnaires administered at clinic visits and monthly telephone calls.

104 ng-term healthcare costs for hospital stays, clinic visits and morbidity due to a chronic disease.

105 planning to become pregnant were followed by clinic visits and questionnaires through delivery.

106 were conditional on attendance at scheduled clinic visits and receipt of proposed services can incre

107 to report their own symptomatic AEs at most clinic visits and report more AEs than investigators.

108 s paper introduces an explanation for missed clinic visits and subsequent disengagement among patient

109 dary outcomes of interest included number of clinic visits and the need for additional intraocular su

110 Episodes of diarrhea were documented through clinic visits and twice-weekly house visits through 52 w

111 linical evaluation at baseline and at annual clinic visits and via telephone at 6 mo intervals.

112 y rates fell by 50 percent, rates of medical-clinic visits and visits for testing and consultation in

113 swab samples were obtained during quarterly clinic visits and were self-obtained weekly during 12-we

114 sory and motor function tests during routine clinic visits and with serial functional brain imaging s

115 ated complications at T0 (first survivorship clinic visit) and at T1 to T5 (subsequent visits).

116 or CVD (data were collected at the 1992/1993 clinic visit) and incident CVD (ascertained through June

117 CEA was measured at each clinic visit, and CT of thorax, abdomen, and pelvis was

118 eported by the mother at her first antenatal clinic visit, and offspring BMI (height and weight measu

119 rotavirus-specific rates of hospitalization, clinic visits, and deaths due to diarrhea among children

120 alaysia) to derive rates of hospitalization, clinic visits, and deaths related to acute gastroenterit

121 life, more self-reported disability days and clinic visits, and greater clinician-perceived patient d

122 s of 3-month symptoms arising from unplanned clinic visits as a result of severe toxicity.

123 mes were assessed by phone call or in-person clinic visit at 1, 3, 6, and 12 months postcardiac arres

124 cases and controls, and also for the initial clinic visit at which CMV retinitis was diagnosed.

125 Follow-up was based on outpatient clinic visits at 3, 6, and 12 months including Holter-EC

126 veness or reversibility were measured during clinic visits at 8 and 15 years of age.

127 if the mothers intended to attend well-baby clinic visits at a different health facility, or to trav

128 Spirometry was performed during clinic visits at ages 3, 5, 8, and 11 years.

129 sglutaminase autoantibodies at 2 consecutive clinic visits at least 3 months apart.

130 HIV-positive adults were seen at semiannual clinic visits, at which time weight, fat, and fat-free m

131 ong HIV-infected women with >or=1 outpatient clinic visit between January 1997 and December 2004.

132 nic patients who had at least 1 rheumatology clinic visit between January 2001 and July 2002.

133 in samples obtained during 113 (52%) of 216 clinic visits between 1993 and 1997.

134 l in developing countries with a once weekly clinic visit, but optimum duration of chemoprophylaxis h

135 ced the incidence of malaria parasitemia and clinic visits, but iron did not.

136 tient compliance with reporting at scheduled clinic visits, but there is limited evidence about compl

137 proportion who missed two or more scheduled clinic visits by 18 months post-enrolment (among all par

138 he objective was to compare the rate of sick clinic visits by infants aged 43-182 d according to brea

139 redictors of chlamydia infection--reason for clinic visit, clinic type, prior sexually transmitted di

140 blood pressure control (BP </= 140/90 at the clinic visit closest to 12 months after study entry) at

141 Efforts to prevent missed clinic visits combined with moves to minimize barriers t

142 lucose was at least as great as that between clinic visits conducted 8 years apart.

143 Hope at the first clinic visit contributed to the change in self-efficacy

144 At every clinic visit, data were obtained on body weight, dietary

145 d control patients (n=34) matched on initial clinic visit date, length of follow-up, and baseline CD4

146 those receiving placebo (p < 0.0001) at all clinic visits (days 15, 29, 57, and 85).

147 hat elevated BP is often not acted on during clinic visits, demonstrates a potential opportunity for

148 al and confirmatory diagnoses, ophthalmology clinic visits, diagnostic procedures, surgical procedure

149 equired the greatest number of ophthalmology clinic visits, diagnostic tests, and surgical procedures

150 , exposure to plasma obtained during routine clinic visits did not alter BPAEC ET-1 mRNA expression o

151 Height and weight were obtained at both clinic visits; differences in body mass index (BMI) betw

152 ed with weeks before ADS events, the rate of clinic visits during weeks after ADS events increased 2.

153 ltimore, Minneapolis, and San Diego attended clinic visits during which data were collected on diet,

154 Patients with yearly clinic visits, during which standardized assessment of s

155 98, there were on average 3.6 million office/clinic visits each year for angina among adults in the U

156 ctors associated with NCT, such as missing a clinic visit early during treatment, might help identify

157 Incident AF systematically ascertained using clinic visit electrocardiograms, hospital discharge diag

158 ce visits, telephone encounters, after-hours clinic visits, emergency department encounters, and hosp

159 ociated with a significant reduction in sick clinic visits, especially those due to diarrhea.

160 py (START) study, done in 32 countries, with clinic visits every 3 months.

161 sed prospectively from daily diary cards and clinic visits every 6 months.

162 hy (EDI-OCT) scans were obtained at a single clinic visit for 97 uveitic eyes from patients >/=16 yea

163 ed the additional prognostic value of missed clinic visits for all-cause mortality.

164 Office and clinic visits for angina have declined over time.

165 Of 6287 hospitalizations and 2565 clinic visits for ARI, 24% and 12%, respectively, yielde

166 ivariable analysis the total number of acute clinic visits for asthma symptom was significantly assoc

167 on causes 19% of hospitalizations and 16% of clinic visits for diarrhea among children <5 years of ag

168 obulin G were measured, and the incidence of clinic visits for diarrheal illness was determined.

169 An increased rate of clinic visits for fever within 3 days after vaccination

170 The change in VAI between clinic visits for individual patients correlated highly

171 as no difference in the number of outpatient clinic visits for Medicaid and non-Medicaid patients.

172 mber of emergency department and urgent care clinic visits for pediatric patients.

173 The variation in the rates of clinic visits for principal medical care among the netwo

174 lth across space and time by analyzing daily clinic visits for respiratory diseases among preschool a

175 tigated the relationship between the ADS and clinic visits for respiratory diseases in children.

176 ociation between ADS episodes and children's clinic visits for respiratory diseases, controlling for

177 The total number of acute clinic visits for significant troublesome lung symptoms

178 Clinic visit FPG levels did not differ between PTDM and

179 cohort study included patients who made>or=1 clinic visit from January 1998 through December 2005.

180 Serum samples were collected at routine clinic visits from 50 pediatric LTx recipients classifie

181 sitive for anal HPV infection at one or more clinic visits from baseline through a follow-up period t

182 a combination of telephone, home visits, or clinic visits) from an interprofessional team for severa

183 During his clinic visit, he was also observed to have slow and limi

184 At initial clinic visit, her blood pressure was 138/84 with an unre

185 Follow-up was done during clinic visits, home visits, and by mobile phone.

186 the 1997 to 1998 Cardiovascular Health Study clinic visit in 2792 adults aged 72 to 98 years (82.7% w

187 actual condition of the persistence rate for clinic visit in children with asthma requiring controlle

188 Specular microscopy was performed during a clinic visit in cooperative children in the standard upr

189 viewed again after at least 3 mo and another clinic visit in order to understand any ART use in the i

190 nic between 1999 and 2013 (t0), with another clinic visit in the previous 60 days (t-1).

191 ility monitors appear to be useful in timing clinic visits in a compliant population with flexible sc

192 safely substitute for routine postoperative clinic visits in selected ambulatory surgical procedures

193 ohort study, was conducted during regular CF clinic visits in the first 12 months of life at 28 US Cy

194 Is), resulting in the most common reason for clinic visits in the United States.

195 Baseline and follow-up clinic visits included a periodontal examination; blood,

196 Follow-up was based on outpatient clinic visits, including Holter ECGs.

197 Surgical cases and clinic visits increased from 1240 and 3751 in 1993 to 58

198 er's children's hospital, surgical cases and clinic visits increased from 1240 and 3751 to 2592 and 4

199 nalyses of the 944 persons who attended both clinic visits indicated no association between baseline

200 interval-by-interval basis (interval between clinic visits) indicates that increasing cumulative dose

201 12 months, as measured by the presence of a clinic visit, lab test, or ART initiation 6 to 18 months

202 a multivitamin trial was followed at monthly clinic visits (median: 19.7 mo).

203 a crossover clinical study that included two clinic visits (n = 24 each) where each subject was blind

204 sures of health status, such as frequency of clinic visits, need for rehospitalization, medication us

205 Overall, the first follow-up clinic visit occurred 1 week or less after discharge in

206 nt was randomized in March 2010 and the last clinic visit occurred in November 2016.

207 Mean persistence rate for clinic visit of all patients was gradually decreased, 90

208 Five years later, during a routine clinic visit of one of the genotype-positive family memb

209 me process, imposing long waits and multiple clinic visits on patients.

210 rse events for 21 days after each MV, at all clinic visits, on any hospitalization, and for subjects

211 Follow-up blood pressure, measured at a clinic visit or at home, was reviewed.

212 Women were identified during antenatal clinic visits or in the labour wards of public health fa

213 after cART initiation until AMI, death, last clinic visit, or 30 September 2012.

214 s of the viral populations from two separate clinic visits over 1 to 4 weeks showed that the complexi

215 clinic procedures (three to five additional clinic visits over 2-4 wk prior to ARV dispensing).

216 treatment (OR, 1.63), and more than 10 oral clinic visits over the 24-mo study period (OR, 2.02).

217 erent at 1 month and the final postoperative clinic visits (P < 0.001), there was not a correlation b

218 of hospitalizations (P = 0.047), unscheduled clinic visits (P = 0.019), and days of antibiotic treatm

219 hy will be performed uniformly in all cohort clinic visit participants.

220 Only clinic-visit participants (n = 2261), who had uniformly

221 stic regression model was run for OAG in all clinic-visit participants; covariates included age, sex,

222 At each of three clinic visits, participants completed a self-administere

223 ctive study period was 16 weeks, requiring 3 clinic visits per week.

224 The mean number of clinic visits per year was 2.7 (95% CI, 2.5-2.8) for sur

225 Immediately after the clinic visit, physicians independently quantified their

226 terpersonal psychotherapy, nortriptyline and clinic visits, placebo and psychotherapy, or placebo and

227 aluated with slit lamp biomicroscopy at each clinic visit prior to and following phacoemulsification.

228 Clinical status at last pediatric clinic visit prior to transfer was described.

229 he Seattle Angina Questionnaire before their clinic visit, quantifying their frequency of angina duri

230 yzed: gross and net revenue, surgical cases, clinic visits, ranking of the pediatric surgery residenc

231 ntibodies to C. jejuni and O157 LPS, but the clinic visit rate for diarrhea was 46% lower among farm-

232 spital stays), hospital-discharge rates, and clinic-visit rates from 1991 through 1995 for the entire

233 pairment, limitation of activities, repeated clinic visits, recurrent hospitalizations, perception of

234 t, targeted age and frequency, and number of clinic visits required.

235 ity calculator during 474 and 429 outpatient clinic visits, respectively.

236 ; 95% CI: 0.62, 1.13; P = 0.23), unscheduled clinic visits (RR: 0.97; 95% CI: 0.85, 1.10; P = 0.59),

237 In post hoc analysis, clinic visits significantly increased by 43% over the fi

238 ntiretroviral therapy (ART) can take several clinic visits, some children die prior to ART initiation

239 swabs taken from the same woman on the same clinic visit, suggesting that the RNA values from a sing

240 ial and repeat biopsy, follow-up imaging and clinic visits, surgical biopsy (when needed), and treatm

241 After questionnaire completion at each clinic visit, survivors received education tailored to p

242 8 men and 1,998 women attended the follow-up clinic visit that included spirometry at year 5.

243 rbation was diagnosed at 33.0 percent of the clinic visits that involved isolation of a new strain of

244 1, 2, 3, 4, 5-6, and 7-18 over 2 consecutive clinic visits, the odds ratios (ORs) for frequent knee p

245 which pain fluctuation was identified over 3 clinic visits, the relationship of bone marrow lesions (

246 Among a subset of 516 MSM who had at least 3 clinic visits, there was general stability across risk c

247 ces were measured up to 8 times per cycle at clinic visits timed by using fertility monitors.

248 of knowledge, having limited time during the clinic visit to address all problems, patient nonadheren

249 onal hazards models compared time from first clinic visit to death and AIDS-defining events (ADE), ad

250 al to answer a few simple questions during a clinic visit to project individualized probability.

251 ascular admission to hospital, and unplanned clinic visits to treat acute decompensated heart failure

252 controlling for GeoSentinel site and date of clinic visit, to calculate a reporting odds ratio (ROR).

253 height were measured at birth, at scheduled clinic visits up to 1 y, and at 6.5 y; intermediate meas

254 evel and eye-level features recorded for the clinic visit used to match cases and controls, and also

255 ensive therapy would be increased at a given clinic visit using several variables.

256 nduced peripheral neuropathy was assessed at clinic visits using National Cancer Institute criteria a

257 care, experts recommend scheduling frequent clinic visits, using long-acting pain medications, dispe

258 e changes occurred during a steady growth in clinic visit volumes in the associated referral practice

259 of 393 total urine tests and a total of 3986 clinic visits) vs 7.6% in controls (12 positive test res

260 an EVD treatment facility to first survivor clinic visit was 121 days (82-151).

261 750 adults whose principal reason for the clinic visit was a physical symptom.

262 One on-treatment clinic visit was audio recorded for each participant and

263 a specialty clinic, the persistence rate for clinic visit was decreased with time, especially in 6 to

264 y stage of disease (23% of those whose first clinic visit was within 1 year of disease onset versus 2

265 The average number of clinic visits was 12 (range, 1 to 40 visits).

266 Spatial heterogeneity in relative rates of clinic visits was also identified.

267 he value of using fertility monitors to time clinic visits was evaluated in the BioCycle Study (2005-

268 minator, and the virus-specific incidence of clinic visits was extrapolated from the proportion of pa

269 The incidence of influenza virus-associated clinic visits was highest among patients aged 2-17 years

270 nistered to patients with SCD during routine clinic visits was well tolerated and more effective in p

271 rocardiographic characteristics at the first clinic visit were analyzed to predict ventricular fibril

272 co Hospital, University of Milan in the same clinic visit were imaged by 7 different OCT-A devices: O

273 Patients who preferred a clinic visit were seen accordingly.

274 I hospitalizations and 784 controls with 790 clinic visits were enrolled and tested for HRV.

275 359313 clinic visits were included.

276 Beyond HIV retention core indicators, missed clinic visits were independently associated with all-cau

277 Follow-up telephone calls and clinic visits were planned to alternate at 3-month inter

278 mortality, hospitalizations, and unscheduled clinic visits were recorded.

279 Clinic visits were scheduled every 3 months, and MRI was

280 Clinic visits were similar with regard to duration betwe

281 Missed clinic visits were the most important risk factor for fa

282 nital herpes; (2) 39 of the same women at 46 clinic visits when asymptomatic; (3) 55 HSV-2 seropositi

283 ons for vaso-occlusive crisis, and during 12 clinic visits when patients were at the steady state.

284 (mean age, 75 years) at a 1992-1996 research clinic visit, when urine albumin/creatinine ratio (ACR)

285 ored >or=10 on the PHQ-9 during at least one clinic visit, which corresponds to a symptom severity of

286 herence, treatment interruptions, and missed clinic visits, which are strong determinants of worse HI

287 matic; (3) 55 HSV-2 seropositive women at 60 clinic visits who were never observed with herpetic lesi

288 a substitute for the standard postoperative clinic visit with a high degree of patient satisfaction.

289 Neuropathic pain accounts for 25-50% of pain clinic visits with an estimated prevalence of 4 million.

290 2003 in Mbeya, Tanzania: (1) 57 women at 70 clinic visits with clinical genital herpes; (2) 39 of th

291 ouped based on the timing of first follow-up clinic visit within 1 week, 1 to 2 weeks, 2 to 6 weeks,

292 ay readmissions, and number of postoperative clinic visits within 90 days of discharge were not diffe

293 Overall, 1096 (2.7%) of 40,571 clinic visits yielded positive HIV test results.